UC Davis Health researchers have discovered how by-products of the digestion of dietary fiber by gut microbes act as the right fuel to help intestinal cells maintain gut health.
A report examining the European venture landscape for health and biotech firms over the first half of 2017 has found that there is a continuing positive environment for venture funding and M&A in the sector.
Allied Academies invites all the participants from all over the world to attend 7th International Conference on Dementia & Care Practice at Toronto, Canada.
Roche has agreed to out-license certain rights to its invesitgational atropic dermatitis drug lebrikizumab to Demira in a deal that could be worth more than $1.4 billion.
Kite Pharma has begun treating the first EU patients with its investigational CAR–T candidate, axicabtagene ciloleucel (axi-cel), in the safety expansion cohort of the ZUMA-1 trial.
The future of researching ways to prevent AD should probably focus on people at risk for developing the disease, said researchers, and should highlight how to improve management of chronic health conditions and education about living healthier.
The National Institute for Health and Care Excellence has issued draft guidelines backing NHS use of Almirall’s Skilarence to treat moderate to severe plaque psoriasis.
Researchers at Uppsala University have developed a new method for very rapidly determining whether infection-causing bacteria are resistant or susceptible to antibiotics.
In2Bones said today that its US subsidiary received FDA clearance for its 5MS Fracture repair and CoLag locking compression screw systems.
According to official Ddu news, the leading global pharmaceutical and medical device B2B online platform and SGS-CSTC (Standards Technical Services Co., Ltd.) will be calling a press conference in Shenzhen, China, on August 18, 2017 to launch their strategic partnership on credit verification and kick off the Ddu Credit Verification Service officially.
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.